ThalA. P., and KinneyJ. M.: On the Definition and Classification of Shock, Progr. Cardiovascular Dis.9: 527–557 (May) 1967.
2.
HardawayR. M., JamesP. M.Jr., AndersonR. W., BredenbergE. E., and WestR. L.: Intensive Study and Treatment of Shock in Man, J.A.M.A.199: 115–126, (Mar. 13) 1967.
3.
MotsayG. J., DietzmanR. H., and LilleheiR. C.: Treatment of Endotoxin Shock, Rev. Surg.26: 381–399 (Nov.-Dec.) 1969.
4.
WeilM. H., and ShubinH.: The VIP Approach to the Bedside Management of Shock, J.A.M.A.207: 337–340, (Jan. 13) 1969.
5.
ShubinH., and WeilM. H.: The Mechanism of Shock Following Suicidal Doses of Barbiturates, Narcotics and Tranquilizer Drugs, with Observations on the Effects of Treatment, Am. J. Med.58: 853–863 (June) 1965.
6.
BaneA. E.: Recent Developments in the Study and Treatment of Shock, Surg. Gynecol. Obstet.50: 849–878 (Oct.) 1968.
7.
FittsC. T.: Vasoactive Drugs in Treatment of Shock, Postgrad. Med.48: 105–109 (Sept.) 1970.
8.
DietzmanR. H., MotsayG. J., and LilleheiR. C.: Drugs in the Treatment of Shock, Pharmacol. Physicians4: 1–5 (Aug.) 1970.
9.
HaddyF. J.: Pathophysiology and Therapy of Shock of Myocardial Infarction, Ann. Intern. Med.73: 809–827, (Nov.) 1970.
BachmannF.: The Paradoxes of Disseminated Intravascular Coagulation, Hosp. Practice, 113–126 (Sept.) 1971.
16.
BredenbergC. E., JamesP. M., CollinsJ., AndersonR. W., MartinA. M.Jr., HardawayR. M.: Respiratory Failure in Shock, Ann. Surg.169: 392–403 (Mar.) 1969.
17.
WebbW. R., WaxS. D., MurakamiT.: The Shock Lung: Pathogenesis and Treatment, J. Miss. State Med. Assoc.13: 77–80 (Mar.) 1972.
18.
WilsonJ. W.: Treatment or Prevention of Pulmonary Cellular Damage with Pharmacologic Doses of Corticosteroids, Surg., Gynecol. Obstet.134: 675–681 (Apr.) 1972.
BaxterC. R., CanizaroP. C., CarricoC. J., and ShiresG. T.: Fluid Resuscitation of Hemorrhagic Shock, Postgrad. Med.48: 95–99 (Sept.) 1970.
21.
GunnarR. M., LoebH. S., PietrasR. J., and TobinJ. R.: Hemodynamic Measurements in a Coronary Care Unit, Progr. Cardiovascular Dis.11: 29–44 (July) 1968.
22.
O'DonohueW. J.Jr.: Current Concepts in the Pharmacologic Approach to Shock, S. Med. J.62: 1402–1405 (Nov.) 1969.
23.
CordayE., and LilleheiR. C.: Pressor Agents in Cardiogenic Shock, Am. J. Cardiology25: 900–912 (June) 1969.
24.
WeilM. H., ShubinH.: Isoproterenol for the Treatment of Circulatory Shock, Ann. Intern. Med.70: 638–641 (Mar.) 1969.
25.
McCabeW. R.: Endotoxin and Bacteremia Due to Gram-Negative Organisms, N. E. J. Med.285: 1342–1343 (Dec. 10) 1970.
26.
MartinC. M., CuomoA. J., GeraghtvM. J., ZagerJ. R., and MandesT. C.: Gram-Negative Rod Bacteremia, J. Infect. Dis.119: 506–517 (Jan.-June) 1969.
27.
HendelesL.: A Guide to Gentamicin Therapy, Drug Intelligence Clin. Pharm.5: 393–396 (Dec.) 1971.
28.
JelliffeR. W., KnightR., BuellJ., KalabaR., and RockwellR.: Computer Assistance for Gentamicin Therapy, Clin. Res.18: 441, 1970.
29.
CutlerR. E., GyselynckA. M., FleetW. P., and ForneyA. W.: Correlation of Serum Creatinine Concentration and Gentamicin Half-Life, J.A.M.A.219: 1037–1041 (Feb. 21) 1972.
30.
McHenryM. C., GavanR. L., GiffordR. W., GeurkinkN. A., OmmenR. A., TownM. A., and WagnerJ. G.: Gentamincin Dosages for Renal Insufficiency, Ann. Intern. Med.74: 192–197, 1971.
31.
McKayD. G., Mueler-BerghausG.: Therapeutic Implications of Disseminated Intravascular Coagulation, Am. J. Cardiology20: 392–410 (Sept.) 1967.
